Overview
Announcements

Ordinary Adjustment | Solactive China Healthcare Disruption Index | Effective 01. December 2021

Solactive China Healthcare Disruption Index:

In the ordinary rebalancing effective open December 01, 2021 the following index composition was implemented:

3SBIO INC 0.817 %
AKESO INC 1.968 %
ALIBABA HEALTH INFORMATION TECHNOLOGY LTD 4.7099 %
ALPHAMAB ONCOLOGY 0.8634 %
ANGELALIGN TECHNOLOGY INC 2.8904 %
BEIGENE LTD 7.616 %
BRII BIOSCIENCES LTD 1.565 %
CANSINO BIOLOGICS INC 3.8136 %
CARSGEN THERAPEUTICS HOLDING 1.0965 %
CHINA MEDICAL SYSTEM HOLDINGS LTD 1.5364 %
CLOVER BIOPHARMACEUTICALS LT 0.6749 %
GENSCRIPT BIOTECH CORP 4.1816 %
HANSOH PHARMACEUTICAL GROUP CO 4.5784 %
INNOCARE PHARMA LTD 1.4478 %
INNOVENT BIOLOGICS INC 4.9171 %
JD HEALTH INTERNATIONAL INC 7.741 %
JOINN LABORATORIES CHINA C-H 2.9259 %
KINTOR PHARMACEUTICAL LTD 1.0606 %
LIFETECH SCIENTIFIC CORP 0.9511 %
MICROPORT CARDIOFLOW MEDTECH 0.5485 %
MICROPORT SCIENTIFIC CORP 2.8818 %
NEW HORIZON HEALTH LTD 0.6152 %
PEIJIA MEDICAL LTD 0.5453 %
PING AN HEALTHCARE AND TECHNOL 1.638 %
REMEGEN CO LTD-H 2.5166 %
SHANDONG WEIGAO GROUP MEDICAL POLYMER CO LTD 2.4201 %
SHANGHAI JUNSHI BIOSCIENCES CO LTD 2.7337 %
SHANGHAI MICROPORT MEDBOT GR 2.793 %
SIMCERE PHARMACEUTICAL GROUP 1.187 %
SINO BIOPHARMACEUTICAL LTD ORD 5.2055 %
VENUS MEDTECH HANGZHOU INC 0.8463 %
WUXI APPTEC CO LTD 8.9125 %
WUXI BIOLOGICS CAYMAN INC 8.1786 %
YIDU TECH INC 1.0196 %
ZAI LAB LTD 2.6038 %